Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Moir, H. Y. Ng, B. Oliver, J. Burgess, V. Krymskaya, J. Black (Sydney, Australia; Philadelphia, United States Of America). Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis. Eur Respir J 2013; 42: Suppl. 57, 4734

Member's Comments

No comment yet.

Related content which might interest you: Combination therapy in the era of immunotherapy Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Cell therapy in ILD Source: ERS Course 2016 Year: 2016 Cell therapy for lung disease Source: Eur Respir Rev, 26 (144) 170044; 10.1183/16000617.0044-2017 Year: 2017 Cell therapy for lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Cell therapy: a novel approach for the treatment of lung cancer and fibrosis Source: Annual Congress 2010 - Too close for comfort: common pathogenic mechanisms in lung cancer and fibrosis Year: 2010 Long-term sirolimus treatment in lymphangioleiomyomatosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Combination of pentoxifylline and steroids in sarcoidosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 269s Year: 2005 Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Stem cell therapy in IPF Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM) Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Outcome of two patients with lymphangioleiomyomatosis without anti-estrogen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 96s Year: 2006 Tuberculosis screening in patients receiving biological therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 First-line therapy Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer Source: Eur Respir Rev 2014; 23: 30-35 Year: 2014 Concomitant radiotherapy and targeted therapies Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019 Effects of two immunosuppressive triple therapies on inflammatory cells in lung Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Effectiveness of oral metronomic Vinorelbine versus Docetaxel as second-line treatment in Non-Small Cell Lung Cancer patients in real life Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020